Delivery Order SPE2DB25D3404-SPE2DB25FULVA

Award Date 1/30/25
Potential Completion Date 1/31/25
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,325.46, is for the delivery of 4567152399 - LISDEXAMFETAMINE 20 MG CAPSULE 100S. This is a Firm Fixed Price Delivery Order contract with a completion date of February 5, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,853.76, is a Delivery Order on an Indefinite Delivery Contract (IDC) for the supply of 4567065651 LISDEXAMFETAMINE 10 MG CAPSULE 100S. The IDC, valued at $999,999,999, serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,699.70, is for the delivery of 4566995949 - LISDEXAMFETAMINE 20 MG CAPSULE 100S. The contract is a Firm Fixed Price Delivery Order, with a period of performance through January 22, 2025. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award, with ID SPE2DB22D3004|SPE2DB25FPM06, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,718.12 Firm Fixed Price Delivery Order contract is for the supply of 4567239595 ! LISDEXAMFETAMINE 40 MG CAPSULE 100S, a medication. The contract has an ultimate completion date of February 12, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite...
This federal contract award is a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of LISDEXAMFETAMINE 40 MG CAPSULE 90S. The $2,470.06 firm fixed price contract was awarded by the Defense Logistics Agency (DLA) on September 28, 2023, with a completion date of September 29, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, as...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,674.03, is for the delivery of 4566923222 ! LISDEXAMFETAMINE 20 MG CAPSULE 100S, a generic prescription drug. The contract has an ultimate completion date of January 15, 2025 and is a firm fixed-price delivery order. This award is not associated with a set-aside program. AmerisourceBergen holds a...
This federal contract award, identified as SPE2DB22D1103|SPE2DB25FTFL3, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,880.96 firm fixed-price delivery order is for the supply of 4567232494 ! LISDEXAMFETAMINE 30 MG CAPSULE 100S, with a completion date of February 12, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,993.24, is a Firm Fixed Price Delivery Order to provide 4567155185 - LISDEXAMFETAMINE 10 MG CAPSULE 100S. The contract has a period of performance through February 5, 2025 and was awarded on February 4, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,587.26 firm fixed-price delivery order contract is for the supply of 100-count lisdexamfetamine 50 mg capsules. The contract has an ultimate completion date of January 28, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,448.61, is for the delivery of lisdexamfetamine 40 mg capsules in 100-count packages. The contract is a Firm Fixed Price Delivery Order with a completion date of January 14, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB25D3404
    Indefinite Delivery Contract
  • SPE2DB25D3404-SPE2DB25FULVA
    Delivery Order

This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,783.60 Firm Fixed Price delivery order contract is for the supply of 4567113134 LISDEXAMFETAMINE 30 MG CAPSULE 100S, which will be delivered by January 31, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order does not have a set-aside designation, indicating open competition.

Generated 5/1/25, 10:12 AM